31st Hemophilia Symposium Hamburg 2000: Epidemiology Inhibitors in Hemophilia Therapy and Monitoring of Bleeds in Acute and Intensive Care Medicine Pediatric Hemostaseology Case Reports

Front Matter....Pages ii-xxx
Johann Lukas Schoenlein Award 2000....Pages 1-4
Front Matter....Pages 5-5
HIV Infection and Causes of Death in Patients with Hemophilia in Germany (Year 1999/2000 Survey)....Pages 7-14
Hemophilia 2000 — the Annual Survey of the Austrian Hemophilia Centers....Pages 15-19
Front Matter....Pages 21-21
Changes in Epitope Specificity and in Distribution of IgG Subtypes of FVIII Antibodies during Immune Tolerance Therapy (ITT) in Hemophilia A Patients with FVIII Antibodies — a Case Report....Pages 23-40
Clinical Experience with the Modified Bonn-Malmö Protocol since 1996....Pages 41-46
Course of Inhibitors in mild Hemophilia A with and without Immune Tolerance Treatment....Pages 47-52
Front Matter....Pages 53-53
Management of Bleeding in Surgery and Intensive Care....Pages 55-66
Front Matter....Pages 67-67
Frequency and Profile of viral posttransfusional Infections in Patients from Hemophilia Center Timisoara....Pages 69-76
Symptomatic Onset of severe Hemophilia A in Childhood is dependent on the Presence of Prothrombotic Risk Factors....Pages 77-80
Differences between Neonates and Adults in Plasmin Inhibitory and Antifibrinolytic Action of Aprotinin....Pages 81-90
Shorter PFA-100 Closure Times (CT) in Neonates than in Adults: Role of Red Cells, White Cells, Platelets, and von Willebrand Factor....Pages 91-97
Front Matter....Pages 99-99
Efficacy and Safety of a High Purity Protein C Concentrate in the Management of Patients with severe Congenital Protein C Deficiency....Pages 101-109
Respective Roles of Factors II, VII, IX, and X in the Procoagulant Activity of FEIBA....Pages 110-113
Capillary Microscopic and Rheological Dimensions for the Diagnosis of von Willebrand Disease in Comparison with other Hemorrhagic Diatheses....Pages 114-129
Evaluation of Denaturing High Performance Liquid Chromatography (DHPLC) in the Analysis of Hemophilia A....Pages 130-140
Front Matter....Pages 141-141
Rheumatoid Arthritis in a Patient with Hemophilic Arthropathy — a Case Report....Pages 143-148
Recurrent Fatal Intracranial Hemorrhage (ICH) in Two Non-Identical Twins suffering from Hemophilia B (Factor IX Activity <1%)....Pages 149-152
Progression of Thrombosis under Low Molecular Weight Heparin without Heparin-Induced Thrombocytopenia in a young Man: a Case Report....Pages 153-158
Cardiac Tamponade in a Patient with acquired Factor VIII Inhibitor and Chronic Renal Failure....Pages 159-160
Endoscopic Cholecystectomy in a 55-year-old Patient with Heparin-Induced Thrombocytopenia Type II and Replacement of Mitral and Aortic Valve and Tricuspid Valve Anular Plasty....Pages 161-165
Front Matter....Pages 167-167
Successful Orthopedic Operations in Hemophilic Adults with Inhibitors against Factor VIII....Pages 169-170
Evaluation of Clinical Efficiency of rFVlla in Pediatrics....Pages 171-178
Risk Factors for Thrombosis in Hemophilia — an Analysis....Pages 179-180
Status of Pain in Patients with severe Haemophilic Arthropathies....Pages 181-185
Results of a Five-Year Clinical Study with a B-domain Deleted FVIII Concentrate (rFVIII-SQ)....Pages 186-196
Outpatient Treatment with Radiosynoviorthesis in Hemophiliac Arthropathy....Pages 197-198
Requirements for Future Hemophilia Treatment from the Patients’ Point of View....Pages 199-200
Front Matter....Pages 201-201
Molecular Basis of von Willebrand Disease Type IIC Miami....Pages 203-207
Hemorrhagic Diathesis through acquired Factor XIII Inhibitor....Pages 208-209
Liver Transplantation in a Patient with severe von Willebrand Disease Type 3: Levels of von Willebrand Factor Following Transplantation....Pages 210-215
Clinical Course and Laboratory Findings in a Patient with a New Mutation Causing Wiskott-Aldrich Syndrome....Pages 216-218
Role of acquired and inherited Prothrombotic Risk Factors in Pediatric Cerebral Venous Thrombosis — Preliminary Results of a Multicenter Case-Control Study....Pages 219-224
Analysis of the Fibrinogen Genes of 40 Patients with Suspicion of Dys-, Hypo- or Afibrinogenemia....Pages 225-230
Front Matter....Pages 231-231
Hereditary Antithrombin Deficiency — Results of a Family Study....Pages 233-238
Elevated Factor IX and Factor XI as Risk Factors for Venous Thrombosis and Stroke....Pages 239-243
Thrombophilic Risk Parameters in Juvenile »Idiopathic« Stroke Patients....Pages 244-251
Inquiry into the Significance of Constantly Raised FVIII Values as a Factor in Thrombophilia....Pages 252-256
Do Statins Increase the Homocysteine Level?....Pages 257-261
Alpha-2-Macroglobulin Level regulates the Anticoagulant Cofactor Activity of Protein S in Cord and Adult Plasma....Pages 262-272
Combined Prothrombotic Defects and Contraceptives — Risk Factor for Deep Venous Thrombosis in Adolescence....Pages 273-277
Front Matter....Pages 231-231
Role of a 23 bp Insertion in Exon 3 of the Endothelial Cell Protein C Receptor Gene in Venous Thrombophilia....Pages 278-282
Back Matter....Pages 283-287